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STUDY PROTOCOL Open Access
Effectiveness of a guided ACT-based self-
help resilience training for depressive
symptoms during pregnancy: Study
protocol of a randomized controlled trial
embedded in a prospective cohort
Anke B. Witteveen1* , Jens Henrichs1, Annika L. Walker1, Ernst T. Bohlmeijer2, Huibert Burger3,
Yvonne Fontein-Kuipers4, Francois G. Schellevis5,6, Claire A.I. Stramrood7, Miranda Olff8,9,
Corine J. Verhoeven1,10,11 and Ank de Jonge1
Abstract
Background: During pregnancy, about 10 to 20% of women experience depressive symptoms. Subclinical
depression increases the risk of peripartum depression, maternal neuro-endocrine dysregulations, and adverse birth
and infant outcomes. Current treatments often comprise face-to-face psychological or pharmacological treatments
that may be too intensive for women with subclinical depression leading to drop-out and moderate effectiveness.
Therefore, easily accessible, resilience enhancing and less stigmatizing interventions are needed to prevent the
development of clinical depression. This paper describes the protocol of a prospective cohort study with an
embedded randomized controlled trial (RCT) that aims to improve mental resilience in a sample of pregnant
women through a self-help program based on the principles of Acceptance and Commitment Therapy (ACT).
Maternal and offspring correlates of the trajectories of peripartum depressive symptoms will also be studied.
Methods: Pregnant women (≥ 18 years) receiving care in Dutch midwifery practices will participate in a
prospective cohort study (n ~ 3500). Between 12 and 18 weeks of pregnancy, all women will be screened for
depression with the Edinburgh Postnatal Depression Scale (EPDS). Women with an EPDS score ≥ 11 will be
evaluated with a structured clinical interview. Participants with subclinical depression (n = 290) will be randomized
to a 9-week guided self-help ACT-training or to care as usual (CAU). Primary outcomes (depressive symptoms and
resilience) and secondary outcomes (e.g. anxiety and PTSD, bonding, infant development) will be collected via
online questionnaires at four prospective assessments around 20 weeks and 30 weeks gestation and at 6 weeks
and 4 months postpartum. Maternal hair cortisol concentrations will be assessed in a subsample of women with a
range of depressive symptoms (n = 300). The intervention’s feasibility will be assessed through qualitative interviews
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in a subsample of participants (n = 20).
Discussion: This is the first study to assess the effectiveness of an easy to administer intervention strategy to
prevent adverse mental health effects through enhancing resilience in pregnant women with antepartum
depressive symptomatology. This longitudinal study will provide insights into trajectories of peripartum depressive
symptoms in relation to resilience, maternal cortisol, psychological outcomes, and infant developmental milestones.
Trial registration: Netherlands Trial Register (NTR), NL7499. Registered 5 February 2019.
Keywords: Peripartum depression, Resilience, Psychological outcome, Infant development, Cortisol
Background
Antepartum depressive symptoms and subclinical de-
pression with prevalence rates ranging from 10 to 20%,
often remain unnoticed by maternity care providers dur-
ing antenatal visits [1]. However, early detection is cru-
cial because symptoms of depression or anxiety may
result in antepartum depression with prevalence rates
ranging from 5 to 13% or in postpartum depression
(PPD) with prevalence rates of 10 to 15% [2, 3]. Because
these depressive disorders are associated with reduced
family functioning, impaired mother-to-infant bonding,
adverse birth outcomes such as preterm birth, and cog-
nitive and behavioral developmental delays in the infant,
they form an essential treatment target [4–10]. A poten-
tial mechanism underlying these associations is stress-
induced neuroendocrine dysregulation of the maternal
Hypothalamic Pituitary Adrenal (HPA)-axis reflected by
increased maternal cortisol levels that, in turn, affects
the functioning of the neonatal HPA-axis [11].
An important protective factor against the develop-
ment of depression is resilience: adapting to and recov-
ering from stress [12]. Promoting resilience and positive
mental health is a priority of the World Health
Organization (WHO) [13]. However, little is known
about resilience in the antepartum period and its pre-
ventive effect on maternal depressive symptoms and in-
fant neurodevelopmental outcomes. In non-pregnant
populations, positive associations between resilience and
psychological well-being have been observed [12]. To
date, only a few small studies have examined associa-
tions between levels of resilience (or related factors) and
maternal depression and depressive symptoms or infant
behavioral and developmental outcomes [14–16]. More
specifically, by examining trajectories of antepartum and
postpartum depressive symptoms in association with
maternal antepartum resilience, psychological well-
being, and developmental outcomes of the young child,
a better understanding of individualized treatment op-
tions can be gained. Recently, researchers of a prospect-
ive cohort study (n = 2466) identified antepartum and
postpartum risk factors (e.g., younger age, smoking, nau-
sea, operative delivery, bonding difficulties, and low part-
ner support) of several maternal depressive trajectories
[17]. However, to date, additional examination of other
psychological characteristics, including resilience and
(chronic) neurobiological correlates associated with
these trajectories, is lacking. New studies may provide
evidence for relevant clinical management and treatment
options for the near future.
Several international guidelines underscore the neces-
sity to screen more adequately for antepartum depres-
sion or (subclinical) symptomatology. Guidelines also
advise maternal healthcare providers to be aware that
women may be unwilling to disclose their mental health
issues and may be reluctant to engage in treatment due
to fear of stigmatization [18, 19]. After detection of sub-
clinical depressive symptoms, there is a clear need for ef-
fective interventions. Despite the advice for high-
intensity psychological interventions such as cognitive-
behavioral therapy (CBT) and interpersonal therapy [18],
these interventions are less effective in women with sub-
clinical antepartum or postpartum depression or show
no effect at all in non-help-seeking women [20, 21]. An
important problem of previous RCTs with high-intensity
interventions to prevent perinatal depression are high at-
trition rates (e.g. on average 20%), likely because preg-
nant women are faced with practical demands (e.g., time
constraints, lack of childcare), the stigma of experiencing
psychological problems during pregnancy and physical
issues [20]. From previous trials, we also know that to
overcome high attrition rates and improve effectiveness,
interventions should be aimed primarily at at-risk
women (e.g., women with subclinical depression) and
should fit the unique preferences and needs of pregnant
women [22–24].
Psychological interventions that aim to improve men-
tal resilience through self-help training might offer a less
stigmatizing and more fruitful approach during preg-
nancy [25]. In general populations, a low level of ante-
partum resilience is associated with an increased risk of
ante- and postpartum depression [26], while improving
resilience has shown to prevent the development and re-
currence of depression and other adverse outcomes such
as PTSD [12, 27]. Interventions that aim to enhance re-
silience by improving stress-recovery in response to daily
stressors, positivity, and flexibility such as Acceptance
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and Commitment Therapy (ACT) have already proven
to be effective for non-pregnant individuals with subclin-
ical depression [28]. Meta-analyses have shown that
ACT, an innovative form of CBT, has a larger potential
to induce psychological benefits and effectiveness in the
long-term than classical CBT approaches [29, 30]. Al-
though a four-session ACT-based group intervention in
pregnancy has recently been developed [31], ACT’s ef-
fectiveness has not yet been evaluated among pregnant
women with subclinical depression.
Exposure to (traumatic) stress before or during preg-
nancy is a significant risk factor for developing peripar-
tum depression and anxiety and may result in less
favorable outcomes for child development, family func-
tioning, and physiological stress dysregulation [32–34].
During the early course of this (ongoing) research pro-
ject, the COVID-19 pandemic unfolded and may have
provoked additional prenatal stressors such as fear of
getting infected, potential adverse health effects for the
(unborn) baby, financial setbacks, and social distancing
measures that may also affect maternity care. Research
into natural disasters has shown that children in utero
exposed to maternal prenatal stress display more adverse
birth outcomes and infant developmental- and health
outcomes [35, 36]. However, little is known about the
potential buffering effect of maternal resilience on ad-
verse effects of prenatal stress (due to e.g. COVID-19)
on maternal mental health and infant development.
In this ongoing prospective cohort study, antepartum
depression levels are measured in Dutch pregnant
women (n = 3500). Subsequently, women with subclin-
ical depression levels will be randomized to a guided
self-help ACT-based resilience program or to care as
usual (CAU). The short- and long-term effectiveness
and feasibility of the intervention will be assessed using
quantitative RCT data at multiple time-points and quali-
tative interviews. The prospective cohort data will be
used to examine trajectories of different levels of peri-
partum depression and identify maternal psychosocial
factors (i.e. stress and resilience) and demographic, neu-




This study is designed as a prospective cohort study with
an embedded randomized controlled trial (RCT) (Fig. 1).
All women participating in the cohort study will be
screened for depression at 12–18 weeks gestation.
Women with subclinical depression will then be ran-
domly allocated to either a guided self-help resilience
program of 9 weeks (intervention) or care as usual
(CAU) provided by maternity healthcare providers. All
participants will be assessed at approximately 14–20
weeks (T1, RCT pre-intervention), at 28–32 weeks (T2,
RCT one week post-intervention) gestation and postpar-
tum at 6 weeks (T3) and 4 months (T4). Birth outcomes
at T3 will be derived through data-linkage with the
Dutch national perinatal registry [37]. Two additional
sub-studies will be conducted to assess: (1) maternal
cortisol levels (hair cortisol concentration (HCC)) in 300
participants randomly selected from the cohort study
following T0, and (2) feasibility of the intervention via
interviews with approximately 20 participants in the
intervention group following T2. The Ethics Review
Board of the VU University Medical Center has ap-
proved the study protocol (certificate number
NL64740.029.18).
Participants, eligibility, and screening
Women are eligible to participate when aged ≥ 18 years,
receiving antepartum care at the moment of inclusion.
Women will be excluded when they do not master the
Dutch language sufficiently. After informed consent, all
women will participate in a screening procedure for de-
pressive symptoms (T0; 12–18 weeks gestation) and sub-
sequent online assessments throughout pregnancy and
postpartum (Fig. 1; T1 – T4).
For the embedded RCT, an additional inclusion criter-
ion is an EPDS score of ≥ 11 [38] with or without a mild
depressive disorder (i.e. a subclinical depression) as
based on a structured clinical interview by telephone
assessing the presence and severity of current depressive
or dysthymic disorders and suicidality with the Mini
International Neuropsychiatric Interview (MINI) supple-
mented with the Sheehan Disability Scale (SDS) [39–41].
The RCT’s exclusion criteria are psychopharmacological
and/or psychological treatment over the past three
months (reported by the participant), a current major
depressive disorder, and/or moderate to high suicide risk
(based on the MINI).
Additional inclusion criteria for the HCC sub-study
are willing to provide a hair sample and sufficient hair
growth at the posterior vertex of the head with a length
of at least 1 cm. Women who used oral corticosteroids
in the previous 3 months will be excluded from partici-
pation in the HCC sub-study.
For the qualitative sub-study, participants in the RCT
will be purposively sampled from the intervention group
to assess the self-help resilience training experiences.
We will include a sample of ca. 20 women. The sample
consists of women with improved EPDS scores (< 11)
and women with continued depressive symptoms at T2
(EPDS score ≥ 11) as well as women who did or did not
complete the full training and modules of the
intervention.
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Recruitment
Since 87% of Dutch women receive midwife-led care
at the onset of pregnancy, participants will mainly be
recruited via midwifery practices (n ≈ 60) throughout
the Netherlands. Midwives will inform eligible pa-
tients about the study (e.g., provide flyers) and ask
women to be approached by a researcher through e-
mail. Women are also recruited via short study leaf-
lets and posters/flyers disseminated in waiting rooms,
via advertising using social media, at pregnancy and
baby shows/exhibitions, and directly via the study tri-
al’s website. Women themselves or their midwives
will submit the client’s contact-details on a secured
access page of the study website. Subsequently,
women will receive a complete subject information
sheet and informed consent form via regular mail and
e-mail with a charge-free return envelope. Women
will be offered at least one week to consider their
participation. If no response is received after two
weeks, women will be sent an e-mail to remind them
of the research and informed consent form.
Study procedure
After providing and receiving informed consent, all par-
ticipants will be screened for depressive symptoms
through online completion of a digital version of the
EPDS and, if the score is ≥ 11, followed by a 10–15 mi-
nutes telephone interview (MINI) to assess the severity
of the depressive symptoms and to assess whether the
participant meets DSM-5 criteria for current depressive
or dysthymic disorders and suicidality. Master’s students
in clinical or research psychology will conduct inter-
views. A healthcare psychologist with expertise in treat-
ing women in the antepartum and postpartum period
will train the students.
In line with international guidelines for psychosocial
care (NICE-Guideline, 2014) and from a medical-ethical
perspective, all participants will receive feedback about
Fig. 1 Flow-chart of the study
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their EPDS symptom level and, if applicable, about the
psychiatric telephone-interview outcome. A copy of the
two-step screening procedure results will also be shared
with the participants’ midwife or obstetrician (for which
participants gave informed consent). Midwives or obste-
tricians will be advised to discuss the outcome with their
client and further monitor their client’s symptoms if
screening results indicate a subclinical depression. If the
MINI psychiatric interview identifies (suspected) major
depressive or dysthymic disorder or suicidal ideations,
they will be advised to refer women to specialized men-
tal healthcare.
To randomly allocate pregnant women with subclin-
ical depression to the intervention or control condition
for the RCT, an independent statistician from the de-
partment of Epidemiology and Biostatistics (VUmc) will
provide a computer-generated blocked randomization
sequence in a 1:1 ratio, stored in individual sealed
opaque envelopes. Block sizes will be undisclosed to en-
sure concealment. Following each RCT inclusion, a re-
search assistant will open the next envelop and allocate
the participant to the intervention or control condition.
After randomization, participants in the control condi-
tion will be informed by mail that they will receive care
as usual from their midwife or obstetrician. Participants
randomized to the intervention condition will receive
the ACT-based self-help book and its pregnancy adapted
supplement.
After the screening procedure (T0), all study-
participants will receive URL-links to the digital base-
line- (T1) and follow-up questionnaires (T2-T4; Fig. 1).
Each digital questionnaire assessment (T1-T4) will take
approximately 30 minutes to complete. Researchers can
analyze data collected through this web-based data-
gathering tool without having access to information
about the allocation.
For the HCC sub-study, a subsample of women will be
asked to donate a hair sample at T1 (100 women with
EPDS score < 11; 150 women with subclinical depres-
sion; 50 women with major depressive or dysthymic dis-
order based on the MINI). Hair samples will be
collected at 14 to 20 weeks’ gestation. Due to COVID-
19, partners (or other family members) will be asked to
collect the participants’ hair samples at home. An in-
struction video will be shared for this purpose. Partici-
pants and their partners will be instructed to watch this
video before hair sample collection to ensure a standard-
ized hair sampling method. Hair strands of approxi-
mately 100 to 150 hairs will be cut as close as possible
from the scalp from a posterior vertex position [42]. The
most proximal 3 cm of hair will be used for laboratory
analysis. Based on a mean hair growth rate of 1 cm per
month, the hair samples reflect the cumulative cortisol
and cortisone secretion of the previous 3 months.
Participants of the HCC sub-study will be asked to pro-
vide additional written informed consent.
For the qualitative sub-study, a sub-sample of women
from the intervention arm will be recruited via ‘purpos-
ively sampling’ approximately two weeks after the post-
intervention assessment (T2). They will participate in a
qualitative interview of 30–40 minutes (provided they
have given additional consent). Interviews will be con-
ducted using a topic-list with open-ended questions ad-
dressing the following substantive points during the
interviews: (emotional) experience of the resilience-
course, experiences of the e-mail coaching, working
mechanisms, and point(s) of improvement of the inter-
vention. Counselors will also be interviewed concerning
the course of the intervention. A trained interviewer will
conduct interviews. Results will provide important infor-
mation for (process)evaluation, optimization, and future
implementation of pregnant subclinically depressed
women’s resilience course.
Intervention
Participants in the intervention group will receive the
ACT-based self-help book with 9 weekly modules
[43]. They will also receive a pregnancy-specific sup-
plement written by one of the developers of the
ACT-based self-help book (author ETB) and two psy-
chologists with expertise in perinatal psychology (au-
thors ABW and JH). The supplement includes
psychoeducation about depressive symptoms during
pregnancy and explanations of ACT. The self-help
book approach consists of acceptance, commitment,
and mindfulness-based strategies and behavioral
change strategies to increase psychological flexibility
and resilience through six main ACT processes: ac-
ceptance, cognitive diffusion, being present, self as
context, values, and committed action [44]. Each
week, participants will follow one of the nine modules
of the self-help book ‘Living to the Full’ [43]. The
participants will reflect on their avoidance and control
strategies and learn how to stop them and come into
contact with their recent experiences. The book also
focuses on raising awareness of significant personal
values and subsequent decision making based on
these values [45]. Each module takes about 2–3 hours
a week (e.g., reading, homework, practicing). Daily
mindfulness exercises of 10 to 15 minutes to reduce
stress are encouraged and provided on audio. After
each week, participants will receive motivational sup-
port through e-mails from trained counselors from
the department of Clinical Psychology. Counselors
will send an e-mail with questions about the progress
during the previous week (e.g., ‘Were you able to per-
form the exercises in this module?‘). Participants are
instructed to respond within two days, after which
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they receive a feedback e-mail from the counselor.
The purpose of e-mail support (of approximately 10
minutes a week in total) is supporting participants in
performing their homework and exercises and provid-
ing answers to questions about the self-help booklet
[45]. The intervention condition and online coun-
selors will be supervised by a clinical psychologist to
monitor women’s possible worsening of symptoms.
For the latter, symptom improvement or deterioration
will be assessed every two weeks in both the interven-
tion and control group with the Patient Global Im-
pression of Change scale (PGI-C) [46].
Care as usual
CAU comprises regular antepartum appointments
with maternity healthcare professionals. Because of
the RCT’s practice-oriented nature and ethical rea-
sons, midwives can refer women of both the interven-
tion and CAU groups for further psychological/
psychiatric treatment if indicated and desired by the
woman. All mental healthcare received by women
from both RCT groups will be assessed at T2 (post-
treatment). As a consequence of this study’s design,
neither participants nor researchers can be blinded to
group allocation. However, to avoid potential contam-
ination, the study information letter initially provided
to potential participants will not include details re-
garding the type of intervention (e.g., ACT [43]).
Trial status
The cohort study with embedded RCT started enrolling
on April 20, 2019. Currently, 757 participants have been




Depressive symptoms will be assessed with the 10-item
Edinburgh Postnatal Depression Scale (EPDS) [47, 48].
The EPDS has been validated to screen for mild or
major depression both antepartum and postpartum [49].
A Dutch validated EPDS version with good internal val-
idity with a Cronbach’s alpha of 0.83 [48] and good con-
current and predictive validity is available [38]. The ten
items’ response options range from 0 to 3, with higher
scores indicating more depressive symptoms. For inclu-
sion, a cut-off of ≥ 11 will be used since sensitivity and
specificity for depression at this cut-off are estimated to
be 0.83/0.90 in the antepartum period [18, 38, 50].
Resilience will be measured with the Dutch version
of the Mental Health Continuum-Short Form (MHC-
SF) (T2-T4; Table 1). Mental health or well-being
acts as a resilience resource that buffers against psy-
chopathology. The MHC-SF has 14 items that are
scored on a 6-point scale ranging from 0 to 5 (never,
rarely, sometimes, regularly, often, or (almost) always)
and captures three dimensions: emotional (3 items),
psychological (6 items) and social well-being (5 items)
over the past 4 weeks. The Dutch version has shown
good psychometric properties, is reliable (internal reli-
ability of alpha 0.89 on MHC-SF total; and alpha’s of
resp. 0.83, 0.83, and 0.74 on emotional, psychological,
and social well-being subscales resp.) and was vali-
dated in a Dutch sample (n = 1621) [51]. With the
MHC-SF, well-being can be distinguished into flour-
ishing, neither flourishing nor languishing, and lan-
guishing (i.e., absence of well-being) [52].
Secondary outcomes
The following secondary outcomes will be obtained from
participants. The exact time of administration can be
found in Table 1.
 Quality of life will be assessed with the Dutch
version of the Short-Form 12 item Health Survey
(SF-12) [53] and during the intervention with the
one-item version of the Patient Global Impression of
Change scale (PGI-C) [46].
 Care use will be assessed with part two of the
Trimbos/iMTA questionnaire of the Costs
associated with Psychiatric Illness (TiC-P) [54].
 State anxiety will be assessed with the 6-item STAI-
State (i.e. the STAI-S) [55]. The 6-item STAI-S was
constructed and validated previously [56, 57].
 Pregnancy specific anxiety will be assessed with the
revised 10-item version of the Pregnancy Specific
Anxiety Questionnaire-Revised (PRAQ-R2) suitable
for both primi- and multiparous women [58].
 PTSD symptoms will be assessed with the 24-item
Traumatic Event Scale-B (TES-B) specified to
childbirth as the traumatic event [59].
 Mother-to-infant bonding will be assessed with
the 5-item Prenatal and Postnatal Bonding Scale
(PPBS) [60].
 Experience of childbirth will be assessed with the
22-item Childbirth Experience Questionnaire
(CEQ-2) [61].
 Questions concerning breastfeeding and work
resumption (T3 and T4) are based on the DELIVER
study and have been adapted by the research team
[62].
 The Dutch 3 and 4 months version of the Ages and
Stages Questionnaires-3 (ASQ-3) will be used to
assess five infant developmental domains:
Communication, Gross Motor, Fine Motor, Problem
Solving, and Personal Social [63, 64].
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Table 1 Measurements at each time-point of the study
T* birth outcomes PERINED data aPart 2 of the Tic-P with questions regarding psychotropic drug use and psychosocial support. bCase report form completed by e-
mail counselors during intervention period
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 The revised version 37-item version of the Infant
Behaviour Questionnaire (IBQ-R) will be used to
assess the infant’s temperament, as reported by the
mother. The IBQ-R items were slightly changed to
make it available for assessment of 6-week old in-
fants [65, 66].
 Obstetric variables such as birth weight and preterm
birth will be extracted from the Perinatal Registry
database of the Netherlands [37].
Mediators/moderators
 Psychological flexibility will be assessed with the
Dutch version of the 7-item Action and Acceptance
Questionnaire-II (AAQ-II) [67].
 Mindfulness will be assessed with the Dutch version
of the 14-item short form of the Freiburg
Mindfulness Inventory (FMI-SF NL) [68].
 Coping with negative life events over the past year
will be assessed with the Cognitive Emotion
Regulation Questionnaire (CERQ) [69].
 COVID-19 related events experienced by (pregnant)
women will be assessed with three closed questions
about women’s health, the health of close relatives
and financial setbacks, and three closed questions
regarding the peripartum maternity care received.
 A potential (posttraumatic) stress reaction due to
events like the COVID-19 crisis will be assessed with
the Primary Care PTSD Screen for DSM-5 (PC-
PTSD-5) validated in Dutch [70, 71].
 Satisfaction with obstetric care will be assessed with
the 11-item Pregnancy and Childbirth Questionnaire
(PCQ) validated in Dutch [72].
 Physical activity during pregnancy will be assessed
with the short-form of the international physical
activity questionnaire (IPAQ) [73].
 To assess satisfaction with the intervention, the
Dutch version of the 8 item Client Satisfaction
Questionnaire-8 will be used [74–76].
 To assess the (cumulative) cortisol concentration,
hair samples will be weighted, cut with surgical
scissors, and washed with 1.0 mL of LC-MS grade
isopropanol for 2 min. The extraction of cortisol will
be achieved by overnight incubation with methanol
and analyzed with the LC-MS/MS grade including
matrix interferences [77].
Sociodemographic and medical variables
Sociodemographic and medical variables (T1) (e.g.,
smoking, alcohol use, age, parity, SES, ethnicity, ges-
tational age, height and pre-pregnancy weight status,
and work status) will be assessed with the
pregnancy-adjusted Rotterdam Quality of Life




The medium effect (Cohen’s d) of ACT treatment on de-
pressive symptoms lies between 0.4 and 0.6 [30, 79].
With a significant α level of 0.05 and 80% power we
have to include 290 women to detect a small to moder-
ate effect size (Cohen’s d) of > 0.33 between intervention
and control group. Based on previous ACT-trials with
similar (or even smaller) sample sizes of non-pregnant
moderately depressed individuals, a Cohen’s d of at least
0.57 was found with largest Cohen’s d for women with
increased depression levels at baseline [45, 80]. Assum-
ing an attrition rate of 18% as in previous trials evaluat-
ing the long-term effectiveness of ACT [45, 80], the
current sample-size allows us to detect small to moder-
ate effect sizes (i.e., d = 0.365) with a power of 80% at
the planned follow-up assessment [81]. We aim to in-
clude approximately 60 midwifery practices that will ap-
proach about 6,000 pregnant women, for participation.
Based on an estimated response of 62% [62], we will be
able to enroll approximately 3500 women in the cohort
study of whom ca. 15% will have depressive symptoms
[82]. Of these potential trial participants, 20% and 25%
are expected to refuse participation or will be excluded,
respectively, arriving at about 290 pregnant women with
depressive symptoms to be included in the RCT.
Statistical analyses
Analyses for the RCT will be done on both intention to
treat (ITT) and per-protocol basis. First, to assess differ-
ences in depressive symptoms (EPDS) and resilience
(i.e., well-being assessed with the MHC-SF) between
intervention and control condition, independent t-tests
will be used. The mean change of scores (T2-T1) will be
standardized to interpret effect sizes in terms of Cohen’s
d [83]. Next, ITT analyses will be performed using linear
mixed modeling (LMM) to adequately deal with re-
peated measures data and clustering (i.e., at midwifery
practice level). LMM’s with time, treatment, and time-
by-treatment interactions will be performed to assess the
intervention’s effectiveness in improving continuous pri-
mary outcomes of depressive symptomatology, resili-
ence, and continuous secondary outcomes such as infant
developmental milestones. Chi-square tests will be per-
formed to assess group differences according to dichot-
omous (secondary) outcomes such as subclinical
depression and flourishing incidence. Subsequently, gen-
eralized (binary) linear mixed models (GLMM) will be
used to assess the intervention’s effect on the dichotom-
ous secondary outcomes. To identify predictors of suc-
cessful resilience training, (generalized) linear mixed
Witteveen et al. BMC Pregnancy and Childbirth          (2020) 20:705 Page 8 of 12
models will be used. A multivariable GLMM to identify
potential predictors of treatment success will be con-
ducted in two steps: (1) univariable analyses to examine
whether the potential predictor is significantly associated
with the dichotomous outcome and (2) including signifi-
cant predicting variables (p < .10) in the final multivari-
able model to identify independent predictors using the
forward selection procedure. Finally, moderation and
mediation analyses will be conducted to explore possible
working mechanisms (psychological flexibility and mind-
fulness) of the intervention on maternal depressive
symptomatology, resilience, and behavioral and infant
developmental outcomes.
For the longitudinal data, latent class analyses will be
used to explore different trajectories of depressive symp-
toms based on four repeated assessments over time.
Correlates (e.g., cortisol levels) of perinatal depressive
trajectories over time will be identified by using (gener-
alized) linear mixed models. Associations between pre-
natal resilience and maternal mental health outcomes,
birth, and infant developmental outcomes will be exam-
ined by using linear mixed models and GEE-analyses.
All (main) analyses will be adjusted for potential con-
founders such as parity, educational level, and ethnicity.
Multiple imputation methods will be used to impute
missing values if missing at random can be assumed.
Audio-recorded qualitative interviews will be tran-
scribed and anonymized. Transcripts of the interviews
will be coded in an open, axial, and selective manner.
Thematic analysis will be performed by two researchers
[84]. After coding the first 3 or 4 interviews separately,
both researchers will discuss the findings to modify the
coding process. The software program MAXQDA will
be used to facilitate the analysis process.
Discussion
There is a lack of effective psychological interventions to
reduce peripartum depressive symptoms and promote
peripartum resilience. The present study is the first to
examine the feasibility and effectiveness of a guided self-
help ACT-based program for pregnant women with sub-
clinical depression to decrease depressive symptoms and
enhance mental resilience in the peripartum period. The
RCT is embedded in a cohort study of pregnant women
with follow-up assessments from early pregnancy up to
4 months postpartum. This cohort study explores the
different trajectories of low to severe levels of depressive
symptoms and examines the role of factors such as
chronic stress, including maternal cortisol levels and re-
silience in relation to maternal mental health outcomes,
birth- and infant developmental outcomes.
This study has several strengths: it will fill knowledge
gaps concerning the effectiveness of interventions ad-
dressing the enhancement of resilience and the
reduction of depressive symptoms among pregnant
women with subclinical depression. If the ACT-based
self-guided resilience training is shown to be effective, it
will have important clinical implications as it is one of
the first non-stigmatizing, easily accessible interventions
for pregnant women. The ACT-based guided self-help
intervention could fulfill an important role in the needed
and strongly recommended prevention of peripartum
clinical depression and its adverse consequences for both
mother and child [85]. Using a self-help booklet with e-
mail coaching may be particularly useful for women with
mild to moderate depressive symptoms as it will prob-
ably result in better retention rates compared to face-to-
face psychological or pharmacological interventions [20].
Furthermore, ACT has a unique transdiagnostic poten-
tial to affect a broader range of outcomes than depres-
sive symptom reduction alone (e.g., anxiety and stress-
related symptoms) and has shown to improve long-term
outcomes even beyond the peripartum period [79].
Second, embedding this RCT in a prospective co-
hort study provides an excellent opportunity to
examine trajectories of mental resilience factors and
levels of peripartum depressive symptomatology in
association with several maternal and child out-
comes. To date, associations between resilience and
psychological well-being have only been examined in
non-pregnant populations, and associations between
resilience factors and maternal or child outcomes
have only been assessed in a few small-scale (longi-
tudinal) studies [14–16].
Third, instead of cortisol from blood or saliva, antepar-
tum hair cortisol levels will be assessed that are less in-
vasive to obtain and will offer a more stable cumulative
longitudinal measure of the maternal HPA-axis that can
be linked to different levels of antepartum depressive
symptoms and adverse maternal and child outcomes
[86]. Furthermore, the association between antepartum
resilience and chronic hair cortisol has only been studied
once [87]. This study showed that pregnant women who
were more resilient had lower hair-cortisol levels in the
third trimester and less postpartum depressive symp-
toms, indicating the potential of resilience to prevent
negative (mental) health outcomes in pregnant women
and their offspring [87].
A limitation of this study is that multiple clinical self-
assessments during the intervention period may reduce
compliance and increase drop-out rates. However, we
expect that continued participation will be encouraged
through weekly positive interactions with the e-mail
counselors. Compliance to fill out the baseline and
follow-up assessments will be facilitated by using easily
accessible online questionnaires. Another potential limi-
tation is the maternal (and not paternal) report of infant
developmental milestones, which might cause reporter
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bias, particularly in women with more depressive
symptomatology.
In conclusion, the cohort data will deliver essential
data to identify the role of resilience in relation to de-
pression status during pregnancy and postpartum mater-
nal and infant health. These longitudinal findings will
also contribute to the development and strengthening of
(existing) intervention strategies. With the embedded
trial, the effectiveness of a pregnancy-adapted ACT-
based self-help program in promoting resilience and re-
ducing peripartum depressive symptoms will be evalu-
ated. If successful, this will offer women and maternal
healthcare providers a therapeutic option that is easy to
incorporate into standard maternal care. Ultimately, it
will also enhance more long-term resilience that may
prevent postpartum mental health problems like depres-
sion, bonding difficulties, or postpartum traumatic
stress.
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